Market Outlook
The global In - Vitro ADME Services market size was valued at USD 819.5 million in 2022 and is forecast to a readjusted size of USD 1452.2 million by 2029 with a CAGR of 8.5% during review period.
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
Global In - Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia, Evotec, etc. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific.
This report is a detailed and comprehensive analysis for global In - Vitro ADME Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global In - Vitro ADME Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global In - Vitro ADME Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global In - Vitro ADME Services market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global In - Vitro ADME Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In - Vitro ADME Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In - Vitro ADME Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segmentation By Type
Small Molecules
Biologics
Biopharmaceutical Companies
Government and Academic Institutes
Others
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the In-Vitro ADME Services Market in 2025?
The In-Vitro ADME services market is expected to benefit from the growing demand for drug development and personalized medicine. These services offer cost-effective, time-efficient, and accurate alternatives to traditional animal testing, making them highly attractive to pharmaceutical companies. Their ability to simulate human responses in drug metabolism, absorption, distribution, and excretion is a key strength driving market growth.
What are the weaknesses of the In-Vitro ADME Services Market in 2025?
One weakness of the market is the limited ability of in-vitro models to completely replicate the complexity of human physiology. While advancements have been made, there is still room for improvement in ensuring the accuracy of results across different patient demographics. Moreover, the reliance on highly specialized expertise and technology may limit market access for smaller firms.
What opportunities exist in the In-Vitro ADME Services Market in 2025?
As the pharmaceutical industry increasingly focuses on the reduction of animal testing and regulatory pressures tighten, there is an opportunity for companies offering in-vitro ADME services to expand their market share. Additionally, the integration of AI and machine learning to predict drug interactions and streamline drug development presents a promising opportunity for innovation in this field.
What are the threats to the In-Vitro ADME Services Market in 2025?
One of the key threats to the market is the potential for regulatory changes that may impact the use or validation of in-vitro models. Furthermore, competition from other drug testing methods, such as organ-on-a-chip technologies, could pose challenges. The market may also face resistance from traditional pharmaceutical companies reluctant to adopt new technologies.
Market PESTEL Analysis
What are the political factors influencing the In-Vitro ADME Services Market in 2025?
Government regulations promoting the reduction of animal testing and the adoption of more ethical, reliable alternatives play a significant role in shaping the market. Policies that encourage innovation in drug testing technologies and offer incentives for research and development further support the growth of in-vitro ADME services.
What economic factors are affecting the In-Vitro ADME Services Market in 2025?
Economic factors such as the increasing investments in pharmaceutical R&D and the rising costs of drug development are driving the demand for more cost-effective solutions, like in-vitro testing. Additionally, the growing need to optimize drug development timelines in response to economic pressures is boosting the adoption of in-vitro ADME services.
How do social factors impact the In-Vitro ADME Services Market in 2025?
There is growing public awareness and demand for more ethical drug testing methods. Consumers are more conscious of the ethical implications of animal testing, pushing pharmaceutical companies and regulatory bodies to adopt in-vitro alternatives. This shift in societal values favors the expansion of in-vitro ADME services.
What technological factors are shaping the In-Vitro ADME Services Market in 2025?
Technological advancements, particularly in AI and machine learning, are enhancing the capabilities of in-vitro models, making them more accurate and efficient. The integration of high-throughput screening technologies and better predictive modeling techniques has significantly improved the precision of in-vitro ADME services, fueling market growth.
What environmental factors are influencing the In-Vitro ADME Services Market in 2025?
Environmental sustainability is becoming increasingly important in the healthcare and pharmaceutical industries. In-vitro testing, which reduces the need for animal testing, aligns with green initiatives aimed at minimizing ecological impacts. Furthermore, the shift towards more sustainable research and development practices is pushing the market toward in-vitro alternatives.
What legal factors are affecting the In-Vitro ADME Services Market in 2025?
The legal landscape is heavily influenced by regulatory bodies that set the standards for drug testing and approval processes. Stricter laws regarding animal testing and new regulations that promote alternative testing methods provide a legal incentive for pharmaceutical companies to invest in in-vitro ADME services. Additionally, intellectual property laws surrounding these technologies can affect market dynamics.
Market SIPOC Analysis
Who are the suppliers in the In-Vitro ADME Services Market in 2025?
Suppliers in the in-vitro ADME services market include biotechnology companies, research organizations, and providers of laboratory equipment and reagents. These suppliers offer the necessary tools, technologies, and materials that support in-vitro testing, such as cell cultures, enzymes, and specialized testing kits.
What are the inputs to the In-Vitro ADME Services Market in 2025?
The inputs to this market include scientific expertise, advanced laboratory equipment, bioreactors, software tools for data analysis, and chemical compounds used for testing. Research and development activities are essential inputs that drive innovation and improve the accuracy of in-vitro ADME models.
What are the processes in the In-Vitro ADME Services Market in 2025?
Processes in this market include cell-based assays, testing for drug absorption, distribution, metabolism, and excretion (ADME) profiles, data analysis, and model optimization. These processes aim to assess the pharmacokinetics of potential drugs and provide critical information to pharmaceutical companies to streamline drug development.
Who are the customers of the In-Vitro ADME Services Market in 2025?
Customers of in-vitro ADME services include pharmaceutical companies, contract research organizations (CROs), academic institutions, and biotechnology firms. These customers rely on accurate ADME testing to accelerate drug development, improve safety, and reduce the costs and time involved in clinical trials.
What are the outputs of the In-Vitro ADME Services Market in 2025?
The outputs of this market include detailed reports and data on the ADME properties of drugs, which inform pharmaceutical research and decision-making. These outputs support the optimization of drug formulations and help to predict the safety and efficacy of new drugs before clinical trials.
Market Porter's Five Forces
How strong is the threat of new entrants in the In-Vitro ADME Services Market in 2025?
The threat of new entrants is moderate. While the market offers growth opportunities, new entrants face significant barriers such as high research and development costs, the need for specialized knowledge, and establishing relationships with pharmaceutical companies. Moreover, existing players benefit from established reputations and resources, making it challenging for newcomers to compete.
How intense is the bargaining power of suppliers in the In-Vitro ADME Services Market in 2025?
The bargaining power of suppliers is moderate to high. Key suppliers of lab equipment, reagents, and technology hold significant power, especially when offering specialized tools and advanced testing technologies. However, the increasing number of suppliers and the ability of companies to switch suppliers to some extent can help reduce this power.
How intense is the bargaining power of buyers in the In-Vitro ADME Services Market in 2025?
The bargaining power of buyers is moderate. Pharmaceutical companies and research organizations often have specific needs, which gives them some negotiating leverage. However, due to the specialized nature of in-vitro ADME services and the complexity involved, buyers may be less likely to switch providers frequently, which reduces their overall bargaining power.
How strong is the threat of substitute products or services in the In-Vitro ADME Services Market in 2025?
The threat of substitutes is moderate. Alternative methods like animal testing, computational models, and organ-on-a-chip technologies exist, but they are either less accurate or more costly. However, as new technologies emerge, there is the potential for substitution, especially if they offer more precise, cost-effective, or faster results.
How intense is the competitive rivalry in the In-Vitro ADME Services Market in 2025?
The competitive rivalry is high. The market is characterized by several established players offering similar services, leading to intense competition. To differentiate, companies must continuously innovate and invest in improving the accuracy and efficiency of their testing methods. Additionally, growing demand for personalized medicine and drug development intensifies competition.
Market Upstream Analysis
What are the key upstream factors influencing the In-Vitro ADME Services Market in 2025?
Key upstream factors include advancements in biotechnology, improvements in laboratory technologies, and the increasing availability of specialized reagents and tools. These innovations are crucial for enhancing the precision and efficiency of in-vitro ADME testing, enabling providers to offer more accurate results to pharmaceutical clients.
What role does research and development play in the In-Vitro ADME Services Market in 2025?
Research and development (R&D) is a critical upstream factor, driving the continual improvement of in-vitro testing methods. Investment in R&D helps companies refine existing technologies, develop new models for ADME testing, and keep pace with evolving regulatory requirements, all of which are essential for maintaining a competitive edge in the market.
How do regulations impact the upstream activities in the In-Vitro ADME Services Market in 2025?
Regulations significantly affect upstream activities by setting standards for safety, ethical practices, and the acceptance of in-vitro ADME testing methods. Stricter regulations on animal testing and more supportive guidelines for in-vitro alternatives drive investment in innovation and ensure that services meet legal and ethical requirements.
How does the availability of skilled labor affect the In-Vitro ADME Services Market in 2025?
The availability of skilled labor is a crucial upstream factor, as the complexity of in-vitro ADME testing requires highly trained scientists and technicians. Shortages in skilled professionals can limit a company’s ability to scale up operations and deliver high-quality services. Therefore, investing in talent development and training is essential to maintain competitiveness in the market.
How do supplier relationships influence the In-Vitro ADME Services Market in 2025?
Strong supplier relationships play a vital role in the upstream supply chain by ensuring timely access to the necessary materials, reagents, and technologies. Suppliers of specialized components and equipment contribute significantly to the accuracy and reliability of in-vitro ADME services. Collaborative partnerships between service providers and suppliers can help drive innovation and reduce costs.
Market Midstream Analysis
What are the key midstream activities in the In-Vitro ADME Services Market in 2025?
Key midstream activities involve conducting in-vitro ADME testing, data analysis, and reporting. This includes utilizing various testing models, such as cell cultures and high-throughput screening, to evaluate drug absorption, distribution, metabolism, and excretion. The analysis of these results is crucial for understanding the pharmacokinetics of potential drug candidates.
How does technology impact midstream processes in the In-Vitro ADME Services Market in 2025?
Technology plays a critical role in midstream processes by improving the efficiency and accuracy of in-vitro testing. The integration of advanced technologies such as AI and machine learning helps streamline data analysis, predict drug interactions, and optimize testing protocols. Additionally, automation in testing processes can reduce time and costs associated with midstream activities.
How do customer requirements affect midstream activities in the In-Vitro ADME Services Market in 2025?
Customer requirements directly influence midstream activities by shaping the types of tests conducted, the level of detail in the data analysis, and the format of the reports provided. Pharmaceutical companies require precise and reliable ADME data to support decision-making in drug development, which drives service providers to ensure that their midstream processes meet these expectations.
What are the challenges faced during midstream activities in the In-Vitro ADME Services Market in 2025?
Challenges include managing the complexity of drug testing, ensuring consistency and accuracy of results across different models, and addressing variations in patient demographics that may impact drug responses. Additionally, maintaining high standards while managing the cost and time pressures from clients is an ongoing challenge during midstream activities.
How do partnerships impact midstream operations in the In-Vitro ADME Services Market in 2025?
Partnerships between service providers and pharmaceutical companies or research organizations enhance midstream operations by facilitating access to cutting-edge technologies, specialized expertise, and additional resources. These collaborations help streamline the testing process, improve results accuracy, and ensure that services are tailored to meet client-specific needs.
Market Downstream Analysis
What are the key downstream activities in the In-Vitro ADME Services Market in 2025?
Key downstream activities include the delivery of final reports and analysis to clients, such as pharmaceutical companies and research organizations. This involves providing insights on drug safety, efficacy, and pharmacokinetics that guide drug development decisions. These reports are often used in regulatory submissions and clinical trial designs.
How do customer feedback and satisfaction influence downstream activities in the In-Vitro ADME Services Market in 2025?
Customer feedback plays a significant role in downstream activities by helping service providers improve their testing methods and reporting formats. Satisfied clients may lead to repeat business and positive word-of-mouth referrals, while addressing customer concerns ensures the continuous improvement of services, leading to stronger client relationships and better market positioning.
How does the final data analysis impact downstream processes in the In-Vitro ADME Services Market in 2025?
Final data analysis directly impacts downstream processes by determining the quality and actionable insights provided to clients. The accuracy of the data helps inform crucial drug development decisions, such as dosing, formulation, and safety evaluations. Inaccurate or incomplete analysis can lead to delays or errors in clinical development, making robust analysis essential for downstream success.
What challenges exist in the downstream phase of the In-Vitro ADME Services Market in 2025?
Challenges in the downstream phase include ensuring the clarity and usability of data for clients, managing the expectations around turnaround times, and dealing with regulatory hurdles in drug approvals. Additionally, maintaining strong communication with clients to ensure their specific needs are met is critical but can be challenging with complex or highly specialized data.
How do market trends and customer demands influence downstream activities in the In-Vitro ADME Services Market in 2025?
Market trends and customer demands drive the evolution of downstream activities by pushing for faster results, more personalized testing approaches, and compliance with evolving regulatory standards. As the demand for more accurate and personalized drug development grows, service providers must adapt their offerings to meet these new expectations, influencing both the type and format of the final deliverables.
Chapter 1, to describe In - Vitro ADME Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In - Vitro ADME Services, with revenue, gross margin and global market share of In - Vitro ADME Services from 2018 to 2023.
Chapter 3, the In - Vitro ADME Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and In - Vitro ADME Services market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of In - Vitro ADME Services.
Chapter 13, to describe In - Vitro ADME Services research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of In - Vitro ADME Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of In - Vitro ADME Services by Type
1.3.1 Overview: Global In - Vitro ADME Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global In - Vitro ADME Services Consumption Value Market Share by Type in 2022
1.3.3 Small Molecules
1.3.4 Biologics
1.4 Global In - Vitro ADME Services Market by End User
1.4.1 Overview: Global In - Vitro ADME Services Market Size by End User: 2018 Versus 2022 Versus 2029
1.4.2 Biopharmaceutical Companies
1.4.3 Government and Academic Institutes
1.4.4 Others
1.5 Global In - Vitro ADME Services Market Size & Forecast
1.6 Global In - Vitro ADME Services Market Size and Forecast by Region
1.6.1 Global In - Vitro ADME Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global In - Vitro ADME Services Market Size by Region, (2018-2029)
1.6.3 North America In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.4 Europe In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.6 South America In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa In - Vitro ADME Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River In - Vitro ADME Services Product and Solutions
2.1.4 Charles River In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Labcorp
2.2.1 Labcorp Details
2.2.2 Labcorp Major Business
2.2.3 Labcorp In - Vitro ADME Services Product and Solutions
2.2.4 Labcorp In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Labcorp Recent Developments and Future Plans
2.3 Envigo
2.3.1 Envigo Details
2.3.2 Envigo Major Business
2.3.3 Envigo In - Vitro ADME Services Product and Solutions
2.3.4 Envigo In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Envigo Recent Developments and Future Plans
2.4 Curia
2.4.1 Curia Details
2.4.2 Curia Major Business
2.4.3 Curia In - Vitro ADME Services Product and Solutions
2.4.4 Curia In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Curia Recent Developments and Future Plans
2.5 Evotec
2.5.1 Evotec Details
2.5.2 Evotec Major Business
2.5.3 Evotec In - Vitro ADME Services Product and Solutions
2.5.4 Evotec In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Evotec Recent Developments and Future Plans
2.6 Bioduro-Sundia
2.6.1 Bioduro-Sundia Details
2.6.2 Bioduro-Sundia Major Business
2.6.3 Bioduro-Sundia In - Vitro ADME Services Product and Solutions
2.6.4 Bioduro-Sundia In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bioduro-Sundia Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza In - Vitro ADME Services Product and Solutions
2.7.4 Lonza In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lonza Recent Developments and Future Plans
2.8 WuXi AppTec
2.8.1 WuXi AppTec Details
2.8.2 WuXi AppTec Major Business
2.8.3 WuXi AppTec In - Vitro ADME Services Product and Solutions
2.8.4 WuXi AppTec In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 WuXi AppTec Recent Developments and Future Plans
2.9 IQVIA
2.9.1 IQVIA Details
2.9.2 IQVIA Major Business
2.9.3 IQVIA In - Vitro ADME Services Product and Solutions
2.9.4 IQVIA In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 IQVIA Recent Developments and Future Plans
2.10 Tecan Group
2.10.1 Tecan Group Details
2.10.2 Tecan Group Major Business
2.10.3 Tecan Group In - Vitro ADME Services Product and Solutions
2.10.4 Tecan Group In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tecan Group Recent Developments and Future Plans
2.11 Pharmaron
2.11.1 Pharmaron Details
2.11.2 Pharmaron Major Business
2.11.3 Pharmaron In - Vitro ADME Services Product and Solutions
2.11.4 Pharmaron In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pharmaron Recent Developments and Future Plans
2.12 Shanghai Medicilon
2.12.1 Shanghai Medicilon Details
2.12.2 Shanghai Medicilon Major Business
2.12.3 Shanghai Medicilon In - Vitro ADME Services Product and Solutions
2.12.4 Shanghai Medicilon In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Medicilon Recent Developments and Future Plans
2.13 ChemPartner
2.13.1 ChemPartner Details
2.13.2 ChemPartner Major Business
2.13.3 ChemPartner In - Vitro ADME Services Product and Solutions
2.13.4 ChemPartner In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ChemPartner Recent Developments and Future Plans
2.14 Joinn Laboratories
2.14.1 Joinn Laboratories Details
2.14.2 Joinn Laboratories Major Business
2.14.3 Joinn Laboratories In - Vitro ADME Services Product and Solutions
2.14.4 Joinn Laboratories In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Joinn Laboratories Recent Developments and Future Plans
2.15 RTI International
2.15.1 RTI International Details
2.15.2 RTI International Major Business
2.15.3 RTI International In - Vitro ADME Services Product and Solutions
2.15.4 RTI International In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 RTI International Recent Developments and Future Plans
2.16 Eurofins Scientific
2.16.1 Eurofins Scientific Details
2.16.2 Eurofins Scientific Major Business
2.16.3 Eurofins Scientific In - Vitro ADME Services Product and Solutions
2.16.4 Eurofins Scientific In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Eurofins Scientific Recent Developments and Future Plans
2.17 Aragen Life Sciences
2.17.1 Aragen Life Sciences Details
2.17.2 Aragen Life Sciences Major Business
2.17.3 Aragen Life Sciences In - Vitro ADME Services Product and Solutions
2.17.4 Aragen Life Sciences In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Aragen Life Sciences Recent Developments and Future Plans
2.18 Sai Life Sciences
2.18.1 Sai Life Sciences Details
2.18.2 Sai Life Sciences Major Business
2.18.3 Sai Life Sciences In - Vitro ADME Services Product and Solutions
2.18.4 Sai Life Sciences In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Sai Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In - Vitro ADME Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of In - Vitro ADME Services by Company Revenue
3.2.2 Top 3 In - Vitro ADME Services Players Market Share in 2022
3.2.3 Top 6 In - Vitro ADME Services Players Market Share in 2022
3.3 In - Vitro ADME Services Market: Overall Company Footprint Analysis
3.3.1 In - Vitro ADME Services Market: Region Footprint
3.3.2 In - Vitro ADME Services Market: Company Product Type Footprint
3.3.3 In - Vitro ADME Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global In - Vitro ADME Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global In - Vitro ADME Services Market Forecast by Type (2024-2029)
5 Market Size Segment by End User
5.1 Global In - Vitro ADME Services Consumption Value Market Share by End User (2018-2023)
5.2 Global In - Vitro ADME Services Market Forecast by End User (2024-2029)
6 North America
6.1 North America In - Vitro ADME Services Consumption Value by Type (2018-2029)
6.2 North America In - Vitro ADME Services Consumption Value by End User (2018-2029)
6.3 North America In - Vitro ADME Services Market Size by Country
6.3.1 North America In - Vitro ADME Services Consumption Value by Country (2018-2029)
6.3.2 United States In - Vitro ADME Services Market Size and Forecast (2018-2029)
6.3.3 Canada In - Vitro ADME Services Market Size and Forecast (2018-2029)
6.3.4 Mexico In - Vitro ADME Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe In - Vitro ADME Services Consumption Value by Type (2018-2029)
7.2 Europe In - Vitro ADME Services Consumption Value by End User (2018-2029)
7.3 Europe In - Vitro ADME Services Market Size by Country
7.3.1 Europe In - Vitro ADME Services Consumption Value by Country (2018-2029)
7.3.2 Germany In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.3 France In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.5 Russia In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.6 Italy In - Vitro ADME Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2018-2029)
8.3 Asia-Pacific In - Vitro ADME Services Market Size by Region
8.3.1 Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2018-2029)
8.3.2 China In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.3 Japan In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.4 South Korea In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.5 India In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.7 Australia In - Vitro ADME Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America In - Vitro ADME Services Consumption Value by Type (2018-2029)
9.2 South America In - Vitro ADME Services Consumption Value by End User (2018-2029)
9.3 South America In - Vitro ADME Services Market Size by Country
9.3.1 South America In - Vitro ADME Services Consumption Value by Country (2018-2029)
9.3.2 Brazil In - Vitro ADME Services Market Size and Forecast (2018-2029)
9.3.3 Argentina In - Vitro ADME Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2018-2029)
10.3 Middle East & Africa In - Vitro ADME Services Market Size by Country
10.3.1 Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2018-2029)
10.3.2 Turkey In - Vitro ADME Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia In - Vitro ADME Services Market Size and Forecast (2018-2029)
10.3.4 UAE In - Vitro ADME Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 In - Vitro ADME Services Market Drivers
11.2 In - Vitro ADME Services Market Restraints
11.3 In - Vitro ADME Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 In - Vitro ADME Services Industry Chain
12.2 In - Vitro ADME Services Upstream Analysis
12.3 In - Vitro ADME Services Midstream Analysis
12.4 In - Vitro ADME Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global In - Vitro ADME Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global In - Vitro ADME Services Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Table 3. Global In - Vitro ADME Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global In - Vitro ADME Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Charles River Company Information, Head Office, and Major Competitors
Table 6. Charles River Major Business
Table 7. Charles River In - Vitro ADME Services Product and Solutions
Table 8. Charles River In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Charles River Recent Developments and Future Plans
Table 10. Labcorp Company Information, Head Office, and Major Competitors
Table 11. Labcorp Major Business
Table 12. Labcorp In - Vitro ADME Services Product and Solutions
Table 13. Labcorp In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Labcorp Recent Developments and Future Plans
Table 15. Envigo Company Information, Head Office, and Major Competitors
Table 16. Envigo Major Business
Table 17. Envigo In - Vitro ADME Services Product and Solutions
Table 18. Envigo In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Envigo Recent Developments and Future Plans
Table 20. Curia Company Information, Head Office, and Major Competitors
Table 21. Curia Major Business
Table 22. Curia In - Vitro ADME Services Product and Solutions
Table 23. Curia In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Curia Recent Developments and Future Plans
Table 25. Evotec Company Information, Head Office, and Major Competitors
Table 26. Evotec Major Business
Table 27. Evotec In - Vitro ADME Services Product and Solutions
Table 28. Evotec In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Evotec Recent Developments and Future Plans
Table 30. Bioduro-Sundia Company Information, Head Office, and Major Competitors
Table 31. Bioduro-Sundia Major Business
Table 32. Bioduro-Sundia In - Vitro ADME Services Product and Solutions
Table 33. Bioduro-Sundia In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bioduro-Sundia Recent Developments and Future Plans
Table 35. Lonza Company Information, Head Office, and Major Competitors
Table 36. Lonza Major Business
Table 37. Lonza In - Vitro ADME Services Product and Solutions
Table 38. Lonza In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Lonza Recent Developments and Future Plans
Table 40. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 41. WuXi AppTec Major Business
Table 42. WuXi AppTec In - Vitro ADME Services Product and Solutions
Table 43. WuXi AppTec In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. WuXi AppTec Recent Developments and Future Plans
Table 45. IQVIA Company Information, Head Office, and Major Competitors
Table 46. IQVIA Major Business
Table 47. IQVIA In - Vitro ADME Services Product and Solutions
Table 48. IQVIA In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. IQVIA Recent Developments and Future Plans
Table 50. Tecan Group Company Information, Head Office, and Major Competitors
Table 51. Tecan Group Major Business
Table 52. Tecan Group In - Vitro ADME Services Product and Solutions
Table 53. Tecan Group In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Tecan Group Recent Developments and Future Plans
Table 55. Pharmaron Company Information, Head Office, and Major Competitors
Table 56. Pharmaron Major Business
Table 57. Pharmaron In - Vitro ADME Services Product and Solutions
Table 58. Pharmaron In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pharmaron Recent Developments and Future Plans
Table 60. Shanghai Medicilon Company Information, Head Office, and Major Competitors
Table 61. Shanghai Medicilon Major Business
Table 62. Shanghai Medicilon In - Vitro ADME Services Product and Solutions
Table 63. Shanghai Medicilon In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Shanghai Medicilon Recent Developments and Future Plans
Table 65. ChemPartner Company Information, Head Office, and Major Competitors
Table 66. ChemPartner Major Business
Table 67. ChemPartner In - Vitro ADME Services Product and Solutions
Table 68. ChemPartner In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ChemPartner Recent Developments and Future Plans
Table 70. Joinn Laboratories Company Information, Head Office, and Major Competitors
Table 71. Joinn Laboratories Major Business
Table 72. Joinn Laboratories In - Vitro ADME Services Product and Solutions
Table 73. Joinn Laboratories In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Joinn Laboratories Recent Developments and Future Plans
Table 75. RTI International Company Information, Head Office, and Major Competitors
Table 76. RTI International Major Business
Table 77. RTI International In - Vitro ADME Services Product and Solutions
Table 78. RTI International In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. RTI International Recent Developments and Future Plans
Table 80. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 81. Eurofins Scientific Major Business
Table 82. Eurofins Scientific In - Vitro ADME Services Product and Solutions
Table 83. Eurofins Scientific In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Eurofins Scientific Recent Developments and Future Plans
Table 85. Aragen Life Sciences Company Information, Head Office, and Major Competitors
Table 86. Aragen Life Sciences Major Business
Table 87. Aragen Life Sciences In - Vitro ADME Services Product and Solutions
Table 88. Aragen Life Sciences In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Aragen Life Sciences Recent Developments and Future Plans
Table 90. Sai Life Sciences Company Information, Head Office, and Major Competitors
Table 91. Sai Life Sciences Major Business
Table 92. Sai Life Sciences In - Vitro ADME Services Product and Solutions
Table 93. Sai Life Sciences In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Sai Life Sciences Recent Developments and Future Plans
Table 95. Global In - Vitro ADME Services Revenue (USD Million) by Players (2018-2023)
Table 96. Global In - Vitro ADME Services Revenue Share by Players (2018-2023)
Table 97. Breakdown of In - Vitro ADME Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in In - Vitro ADME Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key In - Vitro ADME Services Players
Table 100. In - Vitro ADME Services Market: Company Product Type Footprint
Table 101. In - Vitro ADME Services Market: Company Product Application Footprint
Table 102. In - Vitro ADME Services New Market Entrants and Barriers to Market Entry
Table 103. In - Vitro ADME Services Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global In - Vitro ADME Services Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global In - Vitro ADME Services Consumption Value Share by Type (2018-2023)
Table 106. Global In - Vitro ADME Services Consumption Value Forecast by Type (2024-2029)
Table 107. Global In - Vitro ADME Services Consumption Value by End User (2018-2023)
Table 108. Global In - Vitro ADME Services Consumption Value Forecast by End User (2024-2029)
Table 109. North America In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 112. North America In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 113. North America In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 118. Europe In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 119. Europe In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 124. Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 125. Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 130. South America In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 131. South America In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 136. Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 137. Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 139. In - Vitro ADME Services Raw Material
Table 140. Key Suppliers of In - Vitro ADME Services Raw Materials
List of Figures
Figure 1. In - Vitro ADME Services Picture
Figure 2. Global In - Vitro ADME Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global In - Vitro ADME Services Consumption Value Market Share by Type in 2022
Figure 4. Small Molecules
Figure 5. Biologics
Figure 6. Global In - Vitro ADME Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. In - Vitro ADME Services Consumption Value Market Share by End User in 2022
Figure 8. Biopharmaceutical Companies Picture
Figure 9. Government and Academic Institutes Picture
Figure 10. Others Picture
Figure 11. Global In - Vitro ADME Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global In - Vitro ADME Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market In - Vitro ADME Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global In - Vitro ADME Services Consumption Value Market Share by Region (2018-2029)
Figure 15. Global In - Vitro ADME Services Consumption Value Market Share by Region in 2022
Figure 16. North America In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 19. South America In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Global In - Vitro ADME Services Revenue Share by Players in 2022
Figure 22. In - Vitro ADME Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players In - Vitro ADME Services Market Share in 2022
Figure 24. Global Top 6 Players In - Vitro ADME Services Market Share in 2022
Figure 25. Global In - Vitro ADME Services Consumption Value Share by Type (2018-2023)
Figure 26. Global In - Vitro ADME Services Market Share Forecast by Type (2024-2029)
Figure 27. Global In - Vitro ADME Services Consumption Value Share by End User (2018-2023)
Figure 28. Global In - Vitro ADME Services Market Share Forecast by End User (2024-2029)
Figure 29. North America In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 30. North America In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 31. North America In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 32. United States In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 37. Europe In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 39. France In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 45. Asia-Pacific In - Vitro ADME Services Consumption Value Market Share by Region (2018-2029)
Figure 46. China In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 49. India In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South America In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 53. South America In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 54. South America In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 59. Middle East and Africa In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 63. In - Vitro ADME Services Market Drivers
Figure 64. In - Vitro ADME Services Market Restraints
Figure 65. In - Vitro ADME Services Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of In - Vitro ADME Services in 2022
Figure 68. Manufacturing Process Analysis of In - Vitro ADME Services
Figure 69. In - Vitro ADME Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
